Impact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotype.

by Alan L Ho, Elgilda Musi, Grazia Ambrosini, Jayasree S Nair, Shyamprasad Deraje Vasudeva, Elisa de Stanchina, Gary K Schwartz
Published 2012-01-01